Akebia Therapeutics
AKBA
#8184
Rank
HK$2.56 B
Marketcap
HK$9.57
Share price
-3.17%
Change (1 day)
-69.61%
Change (1 year)

Akebia Therapeutics (AKBA) Fails to deliver data

Key failure to deliver metrics for Akebia Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Akebia Therapeutics (AKBA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Akebia Therapeutics (AKBA) - since 2014

Volume in USD (price x number of shares), data since 2014

Akebia Therapeutics (AKBA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026HK$2.74 M-61.33%
2025HK$7.1 M47.59%
2024HK$4.81 M79.6%
2023HK$2.68 M-41.28%
2022HK$4.56 M8.92%
2021HK$4.19 M-18.58%
2020HK$5.15 M43.43%
2019HK$3.59 M-62.25%
2018HK$9.51 M238.71%
2017HK$2.8 M-25.14%
2016HK$3.75 M92.2%
2015HK$1.95 M-88.22%
2014HK$16.56 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
HK$0.12 BHK$0.27 B๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$59.4 MHK$0.41 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
HK$27 MHK$0.42 B๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
HK$4.98 MHK$14.96 M๐Ÿ‡บ๐Ÿ‡ธ USA